Home » Newsletters » BioWorld Science

BioWorld Science

June 12, 2015

View Archived Issues

Tillotts and Numab collaborate on TNF-alpha blockers for inflammatory bowel disease

BEAM alliance formed to combat antibiotic resistance

MRC funds U.K. R&D Vaccines Network

Scripps scientists study mTOR activity in striatum with support from NIH grant

UNCOVER-1 results reveal efficacy of ixekizumab in plaque psoriasis

Cellular Biomedicine to acquire CD40LGVAX vaccine

ASP-8273 well tolerated and active in first-in-human study

Tumor shrinkage observed in the brain with AZD-3759

IPO for Cosmo Pharmaceuticals' Cassiopea subsidiary

Amp biosimilars outlicenses second biosimilar

Blood glucose lowered with AZP-531 in overweight individuals

Avilex Pharma receives Wellcome Trust award to develop ischemic stroke candidate

New molecular imaging probe [99mTc]HYNIC-TCP-1 is selective for colorectal cancer

NanoCarrier files IND application in Japan for phase I trial of NC-6004 in head and neck cancer

Phase II trials of F-351 begin in China

Preclinical data show efficacy of Delenex's DLX-1008 in in vivo models of human glioma

Takeda patents PKR1 antagonists

Chinese team presents antidiabetic compounds

Bayer introduces GLUT-1 inhibitors

Roche discloses autotaxin inhibitors

Cancer Research Technology patents RET inhibitors

TiGenix takes initial steps towards MAA submission for Cx-601

FDA approves Promacta for children age 6 years and older with chronic ITP

No safety concerns during 30 days after first patient dosed with Celyad's NKG2D CAR T-cell therapy

FDA Advisory Committee recommends approval of mepolizumab for severe asthma in adults

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...